Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression

Journal of Clinical Investigation

Volumn 107, Issue 3, 2001, Pages 351-361

  Epling Burnette, P K ^a,e   Liu, Jin Hong ^a   Catlett Falcone, Robyn ^a   Turkson, James ^a   Oshiro, Marc ^a   Kothapalli, Ravi ^a   Li, Yongxiang ^a   Wang, Ju Ming ^b   Yang Yen, Hsin Fang ^b   Karras, James ^c   Jove, Richard ^a   Loughran Jr , Thomas P ^a,d  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c ISIS PHARMACEUTICALS   (United States)

^d UNIVERSITY OF SOUTH FLORIDA   (United States)

^e Hematologic Malignancy Program   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN MCL 1; STAT3 PROTEIN;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; LARGE GRANULAR LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; T CELL LEUKEMIA;

EID: 0035136846     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/jci9940     Document Type: Article

References (58)

1. Clonal diseases of large granular lymphocytes
2. The lymphoproliferative disease of granular lymphocytes: Updated criteria for diagnosis
3. Perforin gene expression in granular lymphocyte proliferative disorders
4. The roles of costimulation and Fas in T cell apoptosis and peripheral tolerance
5. A role for perforin in activation-induced cell death
6. Lymphoproliferative disorder in mice explained by defects in Fas antigen that mediates apoptosis
7. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand
8. Dysregulation of CD95/CD95 ligand-apoptotic pathway in CD3+ large granular lymphocyte leukemia
9. Constitutive activation of Stat3 signaling confers resistance to apoptosis in human myeloma tumor cells
10. The SIF binding element confers sis/PDGF inducibility onto the c-fos promoter
11. Spacing of palindromic half sites as a determinant of selective STAT (signal transducers and activators of transcription) DNA binding and transcriptional activity
12. Design of conditionally active STATs: Insights into STAT activation and gene regulatory function
13. Interleukin 2 signaling involves the phosphorylation of Stat proteins
14. Stat recruitment by tyrosine-phosphorylated cytokine receptors: An ordered reversible affinity-driven process
15. JAK/STAT signaling by cytokine receptors
16. Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway
17. Cytokine signaling for proliferation, survival, and death in hematopoietic cells
18. Activation of STAT transcription factors in oncogenic tyrosine kinase signaling
19. Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein
20. Jak-STAT signaling induced by the v-abl oncogene
21. Activation of STAT3 by the c-Fes protein-tyrosine kinase
22. A single amino acid substitution in the v-Eyk intracellular domain results in activation of Stat3 and enhances cellular transformation
23. Constitutive activation of Stat3 in fibroblasts transformed by diverse oncoproteins and in breast carcinoma cells
24. STAT-related transcription factors are constitutively activated in peripheral blood cells from acute leukemia patients
25. Constitutive activation of JAKs and STATs in BCR-Abl-expressing cell lines and peripheral blood cells derived from leukemic patients
26. Requirement of Stat3 but not Stat1 activation for epidermal growth factor receptor-mediated cell growth in vitro
27. Interferon-alpha resistance in a cutaneous T-cell lymphoma cell line is associated with lack of STAT1 expression
28. Stat3 activation by Src induces specific gene regulation and is required for cell transformation
29. Stat3 as an oncogene
30. Stat3 activation is required for cellular transformation by v-src
31. Mammary gland factor (MGF) is a novel member of the cytokine regulated transcription factor gene family and confers the prolactin response
32. Inhibition of acute lymphoblastic leukemia by a Jak-2 inhibitor
33. STAT3 regulates the growth and immunoglobulin production of BCL (1) B cell lymphoma through control of cell cycle progression
34. mcl-1 is an immediate-early gent activated by the granulocyte-macrophage colony-stimulating factor (GM-CSF) signaling pathway and is a component of the GM-CSF viability response
35. The antiapoptotic gene mcl-1 is up-regulated by the phosphatidylinositol 3-kinase/Akt signaling pathway through a transcription factor complex containing CREB
36. The role of shared receptor motifs and common Stat proteins in the generation of cytokine pleiotropy and redundancy by IL-2, IL-4, IL-7, IL-13, and IL-15
37. STAT5 interaction with the T cell receptor complex and stimulation of T cell proliferation
38. Involvement of an ICE-like protease in Fas-mediated apoptosis
39. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis
40. IFN-alpha is a survival factor for human myeloma cells and reduces dexamethasone-induced apoptosis
41. Interleukin-6 in multiple myeloma and related plasma cell dyscrasias
42. Signals through gp130 upregulate bcl-x gene expression via STAT1-binding cis-element in cardiac myocytes
43. Lymphocyte activation in health and disease
44. Normal clonal expansion but impaired Fas-mediated cell death and anergy induction in interleukin-2-deficient mice
45. Anti-CD3 monoclonal antibody-mediated cytotoxicity occurs through an interleukin-2-independent pathway in CD3+ large granular lymphocytes
46. Activation of leukemic large granular lymphocytes by interleukin-2 via the p75 interleukin-2 receptor
47. Cell membrane expression and functional role of the p75 subunit of interleukin-2 receptor in lymphoproliferative disease of granular lymphocytes
48. Epitope mapping of HTLV envelope seroreactivity in LGL leukaemia
49. HTLV infection and hematologic malignancies
50. Elevated expression of the apoptotic regulator Mcl-1 at the time of leukemic relapse
51. Mcl-1, a gene expressed in programmed myeloid cell differentiation has sequence similarity to Bcl2
52. Mcl-1 a member of the Bcl-2 family, delays apoptosis induced by c-Myc overexpression in Chinese hamster ovary cells
53. Mcl-1, a bcl-2 family member, delays the death of hematopoietic cells under a variety of apoptosis-inducing conditions
54. Mutagenesis of the BH3 domain of BAX identifies residues critical for dimerization and killing
55. BOD (Bcl-2-related ovarian death gene) is an ovarian BH3 domain-containing proapoptotic Bcl-2 protein capable of dimerization with diverse antiapoptotic Bcl-2 members
56. Bok is a pro-apoptotic Bcl-2 protein with restricted expression in reproductive tissues and heterodimerizes with selective anti-apoptotic Bcl-2 family members
57. JAK3, STAT, and MAPK signaling pathways as novel molecular targets for the tyrphostin AG-490 regulation of IL-2-mediated T cell response
58. Protein tyrosine kinase inhibitors as novel therapeutic agents